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ABSTRACT 
 
OBJECTIVES: To compare the ability of body mass index (BMI), waist circumference (WC) 
and waist to height ratio (WHtR) to estimate cardiovascular disease (CVD) risk levels in young 
people.  
 
DESIGN: Systematic review and meta-analysis. 
 
RESULTS: 117 records representing 96 studies with 994,595 participants were included in 
the systematic review, 14 of which (13 studies, n=14,610) were eligible for the meta-analysis. 
The results of the meta-analysis showed that BMI was a strong indicator of systolic blood 
pressure, diastolic blood pressure, triglycerides, high-density lipoprotein cholesterol and 
insulin; but not total cholesterol, low-density lipoprotein or glucose. Few studies were eligible 
for inclusion in the meta-analysis considering WC or WHtR (n≤2). The narrative synthesis 
found measures of central adiposity to be consistently valid indicators of the same risk factors 
as BMI. 
 
CONCLUSION: BMI was a strong indicator of CVD risk. WC and WHtR were efficacious for 
indicating the same risk factors BMI performed strongly for, though there was insufficient 
evidence to judge the relative strength of each measure; possibly due to heterogeneity in the 
methods for measuring and classifying WC.  
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INTRODUCTION 
 
Levels of adiposity, one of the key modifiable risk factors associated with the development of 
cardiovascular disease (CVD) risk in young people (1), have reached concerning levels; with 
over a third of 10-11 year old children already being classified as overweight (OW) or obese 
(Ob) in the UK  (2). The ability to identify individuals with the highest disease risk is important 
in order to effectively target interventions. Thus, valid methods of assessing whether someone 
is normal weight (NW), OW or Ob are essential. Anthropometric measures provide the most 
appropriate methods for doing this due to their relative ease, speed, and low cost (3, 4). There 
are however multiple anthropometric adiposity indexes which have been proposed for this 
purpose. Research is required to elucidate which of these is most efficacious for identifying 
individuals with increased CVD risk factor levels.  
 
Body mass index (BMI) is the most commonly used measure of adiposity. Although BMI is a 
good indicator of general health in young people (5) it does have limitations, including the 
inability to differentiate between individuals with different fat distributions. Studies have 
demonstrated that participants with greater abdominal adiposity may have higher risk than 
those with gluteo-femoral obesity (6, 7). The use of measures of central obesity such as waist 
circumference (WC) and waist-to-height ratio (WHtR) may therefore be important. 
Furthermore, it has been demonstrated that the extent of the obesity epidemic differs when 
different adiposity indexes are used; with BMI potentially underestimating the extent of the 
issue (8, 9). With such variation in the reported prevalence of obesity when different methods 
are used it is clear that establishing which of these measures is most appropriate for identifying 
sub-optimal health is important.  
 
The purpose of the current review and meta-analysis was to investigate whether adiposity 
status classified using BMI is an indicator of CVD risk factors in young people (aged 11-19 
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years) and to establish whether indicators of central adiposity (WC and WHtR) are more 
efficacious for this purpose. 
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METHODS 
 
Search Strategy 
Systematic searches of the following electronic databases were performed up to the end of 
September 2012: The Cochrane Library, the Centre for Review and Dissemination, PubMed, 
the British Nursing Index, CINAHL Plus, the BIOSIS citation index, ChildData, and the 
metaRegister of clinical trials. The primary search terms used were variants of 
“adolescent/adolescence”, “obesity” and “cardiovascular OR cardiovascular risk”; for example 
the search terms for the PubMed search were “(((obesity) AND cardiovascular) AND risk) AND 
(adolescence OR adolescent)”.  
 
Study selection 
Studies were included after the primary database search if, after scrutiny of the title and 
abstract, the study reported at least one adiposity measure and at least one cardiovascular 
disease risk factor in young people (11-19 years of age). All observational studies were eligible 
for inclusion in the review; including cross-sectional studies, cohort studies (prospective or 
retrospective) and case control studies.  
Studies that considered adiposity based on BMI, WC and/or WHtR were eligible for inclusion. 
The outcomes for the review were cardiovascular disease (CVD) risk factors, specifically: 
systolic blood pressure (SBP), diastolic blood pressure (DBP), total cholesterol (TC), 
triglycerides (TG), high-density lipoprotein cholesterol (HDL-c), low-density lipoprotein 
cholesterol (LDL-c), fasting glucose (plasma or serum), and/or fasting insulin (plasma or 
serum).  
 
Quality Assessment 
As no universally recognised quality assessment tool exists for observational studies (10) 
relevant items were taken from both the Newcastle-Ottawa scale (11) and the Cochrane 
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Collaboration’s tool for assessing risk of bias (12). Each item was judged as high, medium or 
low risk based on the following criteria: Low risk, if the study was judged to be “low” risk in all 
categories; medium risk, if the study was judged to be “medium” risk for one to three 
categories; high risk, if the study was judged to be “high” risk for ≥ 1 category and/or “medium” 
risk for ≥ 4 categories. 
 
Analysis  
All studies identified for inclusion were tabulated and reported in a narrative synthesis. Where 
appropriate outcome data were available from the included studies meta-analysis was 
undertaken using RevMan software (Version 5.2. Copenhagen: The Nordic Cochrane Centre, 
the Cochrane Collaboration) for analysis. To be included in the meta-analysis it was required 
that the study compared CVD risk factors between adiposity groups classified using the IOTF 
BMI classification criteria (13), the British WC adiposity status classification methods (14), 
and/or using WHtR groups of <0.5 (NW) and ≥0.5 (OW/Ob) (15). Where studies did not 
categorise participants into adiposity classifications based on these methods study authors 
were contacted to request outcome data according to these categories, or raw data to be 
converted by one author (SW). 
As the outcomes of the review were continuous, meta-analysis of pooled between-group 
differences were calculated in RevMan using a mean difference with 95% confidence intervals 
(95%CI). Statistical heterogeneity was assessed using the I-squared (I2) statistic. For all 
comparisons a random-effects model was applied. Between-group differences (estimated in 
RevMan as Z-scores) were considered significant at P < 0.05. 
The following between-group comparisons were made according to adiposity classification: 
“underweight (UW)/NW” with “OW”, “UW/NW” with “OW/Ob”, “UW/NW” with “Ob”. Sensitivity 
analyses were defined a priori to assess the impact of study quality (with overall high-risk 
studies excluded), study type (cross-sectional, case control or cohort) and country.  
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RESULTS 
Study selection 
The study selection process is reported in the PRISMA diagram (17) in Figure 1. Following 
de-duplication 11,859 citations were identified. Of these 10,325 were excluded at the title 
and/or abstract stage. 1,534 articles were obtained for further screening. Of these 1,357 were 
excluded. Details of these excluded studies and reasons for exclusion are reported in 
supplementary table S1. 96 studies (117 citations) were included in the systematic review, of 
which 13 (14 citations) provided data for the meta-analysis. Details of the included studies are 
presented in Error! Reference source not found. for those included in the meta-analysis and 
in a supplementary table 3 for those included in the narrative synthesis. 
 
Risk of bias and quality assessment 
Of the 13 studies included in the meta-analysis, 4 were classified as high risk of bias, 9 were 
classified as medium risk and none were classified as low risk (Error! Reference source not 
found.).  
 
Meta-analysis results 
No studies were identified that had data available in the required format for inclusion in the 
meta-analysis which measured SBP, DBP, glucose or insulin when classifying adiposity status 
using WC or WHtR.  OW and Ob participants were combined due to the greater availability of 
data in this format.  
SBP was significantly lower in UW/NW participants than OW/Ob participants (-6.81mmHg, 
95%CI -8.71 to -4.90; Figure 2a). A similar pattern was observed for DBP, with significant 
differences between UW/NW participants and OW/Ob participants (-3.53mmHg, 95%CI -5.17 
to -1.53; Figure 2b).  
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TC was not significantly different between adiposity groups (mean difference in UW/NW v 
OW/Ob -0.18mmol·L-1, 95%CI -0.37 to 0.02); though there was divergence in the direction of 
the mean differences between sexes (males had higher TC in the UW/NW group whilst for 
females the values were lower in the UW/NW group; results not presented). Sensitivity 
analyses with high risk studies excluded led to the results for this comparison becoming more 
clearly non-significant (Figure 2c). Results for WC and WHtR in relation to TC were similar to 
those observed for BMI (mean difference in UW/NW v OW/Ob 0.03mmol·L-1, 95%CI -0.10 to 
0.15 and -0.15mmol·L-1, 95%CI -0.36 to 0.06 respectively). 
Triglyceride concentration was significant different between UW/NW and OW/Ob participants 
when classified by BMI (mean difference in UW/NW v OW/Ob -0.19mmol·L-1, 95%CI -0.24 to 
-0.14; Figure 2d). Using WC (Error! Reference source not found.) or WHtR (Error! 
Reference source not found.) the difference in TG was significant between NW and OW/Ob 
participants in the whole sample and in males but there were not sufficient studies to assess 
this validly in females. 
HDL-c concentration was significantly higher in UW/NW than OW/Ob participants when BMI 
was used (mean difference 0.10mmol·L-1, 95%CI 0.06 to 0.14; Figure 2e). For WC adiposity 
classifications HDL-c was significantly higher in NW participants than OW/Ob participants 
(Figure 2f). For all participants and for male participants, HDL-c was significantly different in 
those with a WHtR <0.5 (NW) compared to those with WHtR ≥0.5 (OW/Ob) (mean differences 
0.14mmol·L-1 for all participants and 0.18mmol·L-1 for males) (Figure 2g). 
LDL-c concentrations were significantly different between BMI classification groups when all 
participants were combined (mean difference between UW/NW and OW/Ob -0.11mmol·L-1, 
95%CI -0.21 to -0.01; P=0.04). Sensitivity analyses with high risk studies excluded resulted in 
the outcomes becoming non-significant for all participants and more clearly non-significant 
within male and female sub groups (Figure 2h). 
There was no significant difference between UW/NW and OW/Ob participants’ glucose levels 
(mean difference -0.06mmol·L-1, 95%CI -0.18 to 0.06), nor was there any difference by sex. 
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Insulin concentrations were significantly different between UW/NW and OW/Ob participants 
using BMI (mean difference -29.38pmol·L-1, 95%CI -42.06 to -16.71; Figure 2i).  
Narrative Synthesis Results 
Of the 117 studies included, 115 presented relevant results using BMI (98%), 31 presented 
relevant results using WC (26%) and six presented relevant results using WHtR (5%).  
44/51 studies (86%) found BMI to be related to SBP (or SBP to be significantly different 
between adiposity classification groups) with SBP increasing as BMI or BMI category 
increased. For DBP, 34/45 studies (76%) found the same. 21/21 studies (100%) that looked 
at hypertension without differentiating between SBP and DBP found a significant relationship 
and/or difference; with BP increasing as BMI did. 13/16 studies (81%) found SBP increased 
as WC did.  3/3 studies (100%) found a relationship/difference for WHtR. For DBP, 11/13 
(85%) found an increase in this variable along with an increase in WC. 2/2 studies (100%) 
found a positive association between WHtR and DBP.  
When multiple adiposity classification methods were included, 9/17 studies (53%) could not 
differentiate between the abilities of BMI and WC for indicating elevated BP, two could not 
differentiate between the abilities of all three adiposity indexes whilst the only study to compare 
just BMI and WHtR again could not find a difference between the efficiency of either measure.  
None of the adiposity indexes were consistently effective for predicting TC levels. 19/43 
studies (44%) found a relationship between BMI and TC. For WC, 7/12 (58%) studies found a 
significant relationship. Only 2 studies considered TC alongside WHtR; one of which found a 
significant relationship. Of the 12 studies that considered two of these measures, one study 
found BMI to be superior to WC for indicating heightened TC levels, whilst all others showed 
no clear difference. There was no clear difference in the efficacy of any of the adiposity 
measures in either of the studies comparing all three. 
38/49 studies (78%) showed BMI to be related to TG concentration. 11/14 studies (79%) 
demonstrated the same for WC. 2/3 studies (67%) found WHtR to be an indicator of elevated 
TG. There was little evidence of any superiority of BMI or WC for indicating TG concentration 
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in studies that used both of these measures. There was no difference in the ability of BMI, WC 
or WHtR in the three studies that included all of these adiposity measures. 
37/50 studies (74%) found either a significant relationship between BMI and HDL-c or showed 
that HDL-c levels were significantly different between adiposity classification groups when BMI 
was used. WC was also consistently linked with HDL-c with 14/15 (93%) studies showing this. 
Only three studies considered WHtR and HDL-c, with two of them (67%) showing a significant 
relationship/difference. 4/12 studies (33%) that looked at the relationship of both WC and BMI 
with HDL-c found that WC was associated. 
22/36 studies (61%) found a significant association between LDL-c and BMI. For WC 5/8 
studies (63%) found a significant ability to identify individuals with increased LDL-c. For WHtR 
2/3 (67%) supported this assertion.  
10/28 studies (36%) found a significant relationship between glucose and BMI (or a significant 
difference between adiposity classification groups). 3/6 studies (50%) found a positive 
association between glucose and WC. 1/2 studies (50%) found this with WHtR. No study 
showed a superiority of BMI or WC for indicating fasting glucose levels when only these two 
indexes were used, whilst the only study that compared all three found none of them to be 
related to glucose thus no measure was superior.  
Of the 28 studies looking at the association between insulin and BMI (or the difference in 
insulin between adiposity groups classified using BMI) 27 (96%) found a positive association.  
All of the studies using WC (9/9) found a positive association whilst the only study that used 
WHtR also found a positive association. There was no evidence for the superiority of any of 
the adiposity variables for predicting CVD risk. 
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DISCUSSION 
 
The results from the meta-analysis showed BMI to be a strong indicator of heightened SBP, 
DBP, TG, HDL-c and insulin; with significant differences in the pooled analyses between most 
adiposity classification groups for these variables and a consistent direction of differences 
apparent in associated Forest plots. For TC, LDL-c and glucose the majority of inter-
classification comparisons were non-significant, suggesting that BMI was not a strong 
indicator of these CVD risk factors. These findings are not unexpected as other research has 
also not found a strong association between adiposity and TC or LDL-c in young people  (18, 
19). This lack of relationship may be in part due to the influence of pubertal development on 
these factors (20), or may be a reflection of limitations of using TC and LDL-c as markers of 
health due to possible heterogeneity in their make up (i.e. both include sub-fractions with 
different roles in the development of CVD risk) (21-24). 
 
The outcomes of the current review were similar to those presented in a similar review which 
considered the association of BMI with CVD risk in 5-15 year olds (5). The primary difference 
between the two studies’ findings was that in the current review there was no difference in TC 
or LDL-c concentration between adiposity classification groups, unlike the previous study [7]  
where differences existed between the Ob and NW groups (though not between OW and NW 
participants) of 0.15 and 0.18 mmol·L-1 respectively. Friedemann and colleagues (5) also 
found a significant sex difference for glucose between NW and both OW and Ob participants. 
The magnitude of differences between adiposity classification groups(5) was similar for SBP 
(+4.54 and +7.49 mmHg versus NW in OW and Ob respectively), DBP (+2.57 and +4.06 
mmHg) and insulin (+21.82 and +48.47 pmol·L-1) to those observed in the current study. For 
HDL-c (-0.17 and -0.22 mmol·L-1 versus NW in OW and Ob respectively) and TG (+0.21 and 
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+0.26 mmol·L-1) the differences were smaller in the current study, though in the same 
direction.  
 
Due to the low number of studies that used WC and, particularly, WHtR it is difficult to draw 
strong conclusions regarding whether these methods were as effective as, or superior to, BMI 
for indicating CVD risk in young people. It is possible that this is in part due to the absence of 
internationally recognised WC cut-points, which introduces heterogeneity within the methods 
and precludes the valid pooling of data. The limited data available for the meta-analysis found 
both WHtR and WC to be statistically significant indicators of TG and HDL-c in the pooled 
analysis, though not for TC or LDL-c. The narrative synthesis outcomes suggested WC was a 
useful indicator of SBP (81% of studies supported this), DBP (85%), TG (79%), HDL-c (93%) 
and insulin (100%); but not TC (58%), LDL-c (63%) or glucose (50%); similar to the results 
observed for BMI. Comparable outcomes were seen for WHtR, though the validity of these 
findings is questionable due to the small number of studies included. The 95%CI of all similar 
analyses between adiposity indexes overlapped in the meta-analysis, suggesting there was 
no statistically significant difference in the ability of each adiposity index to identify CVD risk. 
In the studies that directly compared two or more of the adiposity indexes in the descriptive 
review no measure consistently proved superior for any of the CVD risk factors. These findings 
are similar to those of a study with older adolescents, which found that BMI performed equally 
well as an indicator of CVD risk as WC and WHtR in 19-20 year olds in the Seychelles (25); 
providing some support for this conclusion. Without the research base to fully assess the 
suggestion that WC or WHtR may be superior indicators of CVD health in young people it 
cannot be recommended that either of these measures be used to replace (or be applied 
alongside) BMI as a public health tool. 
 
Heterogeneity, particularly that due to differences in methods and participant characteristics, 
is much greater between observational studies than between randomised control trials 
(26)(16), introducing barriers to the validity of pooling data. The use of descriptive analyses 
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based on systematic methods and analysis of patterns through using Forest plots, alongside 
consideration of sources of heterogeneity (26), may be more important and appropriate than 
reliance on single figure outputs of pooled analysis. Within the current study several of the 
sub-analyses had high heterogeneity based on the I2 statistic (27). For TG the I2 values for the 
entire population were higher than they were for each sex, suggesting the variation was due 
to an effect of sex. Variation in the ages of the participants included in each analysis is 
potentially a particularly important source of heterogeneity, for example there were studies 
that had included 12-17 year olds (28) and 14-19 year old (29). Studies often fail to report 
maturation, socio-economic status and ethnicity, all of which are factors which could influence 
the results and thus introduce heterogeneity. The lack of reporting of such details precludes 
the running of sensitivity analyses to fully assess their influence.  
 
Despite the limitations of pooling observational data the validity of the observed outcomes in 
the current study are supported by alternative methods. Firstly, there was consistent 
agreement between the meta-analyses and descriptive analysis results. Furthermore, the 
forest plots demonstrated a consistent finding for all variables where the adiposity index was 
adjudged to be a positive indicator. Forest plots were not presented by Friedemann and 
colleagues (5) (whose study exhibited comparable heterogeneity between studies) in their 
review; thus this can be considered a comparative strength of the current review. Finally, dose-
responses, a key indicator of causality (30), was also observed; with risk increasing as 
adiposity status increased.  
 
 
LIMITATIONS 
The lack of a fully validated quality assessment tool for observational studies may reduce the 
validity of the portion of the study considering the relative risk of bias associated with each 
paper. Overall the method applied was similar to that used in another recent review (5) and is 
considered appropriate. Further, the search strategy could also be considered a limitation. 
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The inclusion of more specific terms may have produced further relevant results, and may 
have increased the number of studies identified evaluating markers of central obesity in 
particular. Based on the large number of studies identified and considered it is likely that the 
identification of papers was comprehensive and the review was valid. Despite these limitations 
the current review still provides valuable information to inform future research and practice. 
 
FUTURE RECOMMENDATIONS AND CONCLUSIONS 
In both meta-analyses and descriptive analyses, BMI was consistently an indicator of SBP, 
DBP, TG, HDL-c and insulin; but not of TC and LDL-c or glucose. There was limited research 
available for either the meta-analysis or descriptive analysis for the consideration of WC and 
WHtR in relation to these risk factors in young people. The data available from both of these 
analyses suggested that measures of central adiposity were valid indicators of the same risk 
factors as BMI. Further research is needed to fully address this question and, importantly, to 
reach agreement regarding the method for measuring adiposity status by WC. Meta-analyses 
of studies using alternative analytical techniques, such as the pooling of results of correlation 
analyses or utilising odds ratios where cut points for elevated levels of CVD risk are applied, 
may also help to address these questions. 
 
The findings of the current study, and all other meta-analyses using observational data, need 
to be considered in the context of major limitations of using such analyses with this type of 
study. This is largely due to the large heterogeneity likely to be present in such study 
populations and methods. The agreement between the meta-analysis findings with those of 
the descriptive review, as well as the consistency of findings observed when analysing Forest 
plots, combined with evidence of a dose-response relationship suggests that the conclusions 
reached in the current study were appropriate. 
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Figure Legends 
Figure 1: PRISMA diagram showing the study selection process. 
Figure 2: (a) Meta-analysis comparing systolic blood pressure (in mmHg) between 
underweight/normal weight and overweight/obese participants classified using IOTF BMI 
criteria. (b) Meta-analysis comparing diastolic blood pressure (in mmHg) between 
underweight/normal weight and overweight/obese participants. (c) Meta-analysis comparing 
total cholesterol concentration (in mmol·L-1) between underweight/normal weight and 
overweight/obese participants, with high risk studies removed. (d) Meta-analysis comparing 
triglyceride concentration (in mmol·L-1) between underweight/normal weight and 
overweight/obese participants. (e) Meta-analysis comparing high-density lipoprotein 
cholesterol concentration (in mmol·L-1) between underweight/normal weight and 
overweight/obese participants. (f) Meta-analysis comparing high-density lipoprotein 
cholesterol concentration (in mmol·L-1) between normal weight and overweight/obese 
participants classified using waist circumference. (g) Meta-analysis comparing high-density 
lipoprotein cholesterol concentration (in mmol·L-1) between normal weight (<0.5) and 
overweight/obese (≥0.5) participants classified using waist to height ratio. (h) Meta-analysis 
comparing low-density lipoprotein cholesterol concentration (in mmol·L-1) between 
underweight/normal weight and overweight/obese participants, with high risk studies removed. 
(i) Meta-analysis comparing insulin concentrations (in pmol·L-1) between underweight/normal 
weight and overweight/obese participants. 
 
Table 1: Summary of studies included in the meta-analysis (n = 13 data sets representing 14 
identified records). 
Table 2: Quality assessment of studies included in the meta-analysis (n = 13). 
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Supplementary Table 1: Mean differences in triglyceride levels between normal weight and 
overweight/obese groups when waist circumference was used as an adiposity index. 
Supplementary Table 2: Mean differences in triglyceride levels between normal weight (<0.5) 
and overweight (≥0.5) groups defined using waist to height ratio. 
Supplementary Table 3: Summary of included Studies. 
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